Every stock has a value inside it.

Comitatus values US stocks from their SEC filings, with every assumption in view.

Open the free screenerSee Pro — $29/mo
Comitatus
ScreenerWatchlistMethod
Search ticker or company
SectorAnyMarket capAny
4,000+ US STOCKS
TICKER A–ZPRICEINTRINSIC VALUEUPSIDE
ACMBACME BancorpNot valued$27.30——
ACMCACME Chemicals$88.75$97.30+9.6%
ACMEACME Corp$84.20$112.40+33.5%
ACMFACME Foods$62.10$66.40+6.9%
ACMGACME Energy$72.90$70.15−3.8%
ACMHACME Health$93.45$118.70+27.0%
ACMIACME Insurance$46.15$55.80+20.9%
ACMMACME Materials$55.40$71.25+28.6%
ACMPACME Power$38.20$44.05+15.3%
ACMSACME Software$148.60$131.20−11.7%
ACME CorpACME · INDUSTRIALS
VALUED FROM 10-K FY2025
INTRINSIC VALUE PER SHARE$112.40
PRICE$84.20
UPSIDE+33.5%
$0PRICE IS 75% OF VALUE
ASSUMPTIONS
Sales growth5-YR AVG 6.4% · 10-K6.0%
NOPAT margin10-K FY2025 · 11.2%11.2%
Discount rate (cost of equity)CAPM · RISK-FREE 4.2%9.0%
Long-term growth (g)PERPETUITY2.5%
EXAMPLE DATA · ACME IS ILLUSTRATIVEESTIMATES, NOT ADVICE
01 · HOW IT WORKSTHREE STEPS

From a ticker to a value, in three steps.

SectorAnyMarket capAny
TICKERPRICEVALUEUPSIDE
ACME$84.20$112.40+33.5%
ACMG$72.90$70.15−3.8%
ACMR$41.75$58.10+39.2%
ACMS$148.60$131.20−11.7%
STEP 1

Screen the market

4,000+ US stocks, each price next to its value. Filter by sector or market cap.

ACME CorpACME
INTRINSIC VALUE PER SHARE$112.40
PRICE$84.20
UPSIDE+33.5%
STEP 2

Open a company

See what one share is worth, built line by line from the company’s own filings.

NOPAT margin13.0%
10-K FY2025 · 11.2%
VALUE$121.85WAS $112.40
UPSIDE+44.7%
STEP 3

Change an assumption

Move growth, margins or the discount rate. The value recalculates as you drag.

02 · METHODSEC EDGAR

Where the numbers come from.

Comitatus reads each company’s 10-K from SEC EDGAR, and builds its model from what was reported.

SOURCE
SEC EDGAR, Form 10-K
COVERAGE
4,000+ US stocks in the screener
INPUTS
Every assumption in view
NOPAT margin11.2%
Operating income 598.1×(1 − tax 21%)÷Revenue 4,212.0=0.1122
ACME CORP · FORM 10-K · FY2025EXAMPLE
Consolidated Statements of Operations
IN MILLIONS20252024
Revenue4,212.03,961.4
Cost of revenue(2,738.0)(2,594.7)
Gross profit1,474.01,366.7
Selling, general and administrative(707.6)(668.3)
Research and development(168.3)(156.5)
Operating income598.1541.9
03 · PRICINGMONTHLY, CANCEL ANY TIME

Free to value.
Pro to stress-test.

FREE$0The screener, every value, every assumption.Open the free screener
  • Screener: 4,000+ US stocks, price against value
  • Intrinsic value for each company covered
  • Adjust every assumption
  • CSV export
PRO$29 /moSee how far the value can move.Get Pro
  • Everything in Free
  • Sensitivity matrix: discount rate × long-term growth
  • Bull, base and bear scenarios
  • A record of what you changed against the defaults
04 · QUESTIONSFAQ

Questions, answered.

01

Where does the data come from?

SEC EDGAR: the 10-K reports companies file themselves. No analyst estimates.

02

Why do some companies say “Not valued”?

When a company’s filings can’t support a sound value, for example after sustained losses, Comitatus leaves it blank rather than guess. It stays in the screener so you can still find it.

03

Can I change the assumptions?

Yes, on the free plan. Move sales growth, NOPAT margin, the discount rate or long-term growth, and the value recalculates as you drag.

04

Is this investment advice?

No. Comitatus is a research tool. Values are estimates, with every assumption in view so you can judge them yourself.

05

What does Pro add?

A sensitivity matrix across discount rate and long-term growth, bull, base and bear scenarios, and a record of every assumption you changed against the defaults.

Find the value inside.

The screener is free. No card needed.

Open the free screenerSee Pro — $29/mo